2,674
Views
6
CrossRef citations to date
0
Altmetric
Neurology

Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal

, , &
Pages 484-491 | Received 20 Sep 2019, Accepted 10 Jan 2020, Published online: 10 Feb 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.